What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.98%Above 5Y avg (0.80%)
Annual Rate
CNY 0.26Paid annual
Payout Ratio
27.5%Sustainable
Last Ex-Dividend
Jul 15, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
94.23BCNY
14.12B · vs all stocks (USD)
Updated Oct 23, 2026
Trailing P/E
25.33x
Updated Oct 23, 2026
Revenue (TTM)
59.84BCNY
8.97B · vs all stocks (USD)
Updated Oct 23, 2026
Profit Margin
6.22%
Updated Oct 23, 2026
Beta
0.2310x
vs all stocks
Updated Oct 23, 2026
52-Week Change
48.80%
vs all stocks
Updated Oct 23, 2026
Market Capitalization
94.23BCNY
14.12B · vs all stocks (USD)
Updated Oct 23, 2026
Enterprise Value
83.53BCNY
12.51B · vs all stocks (USD)
Updated Oct 23, 2026
Trailing P/E
25.33x
Updated Oct 23, 2026
Forward P/E
9.66x
Updated Oct 23, 2026
Price to Sales (TTM)
1.57x
Updated Oct 23, 2026
Price to Book (MRQ)
2.44x
Updated Oct 23, 2026
Enterprise to Revenue
1.40x
Updated Oct 23, 2026
Enterprise to EBITDA
15.46x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 17.36×.Updated Oct 23, 2026
Gross Margin
17.14%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 14.49%.Updated Oct 23, 2026
Profit Margin
6.22%
Updated Oct 23, 2026
Operating Margin
8.92%
Updated Oct 23, 2026
Return on Assets (TTM)
3.96%
Updated Oct 23, 2026
Return on Equity (TTM)
9.99%
Updated Oct 23, 2026
Revenue (TTM)
59.84BCNY
8.97B · vs all stocks (USD)
Updated Oct 23, 2026
Revenue per Share (TTM)
17.68CNYUpdated Oct 23, 2026
Quarterly Revenue Growth
28.60%
Updated Oct 23, 2026
Gross Profit (TTM)
8.67BCNY
1.30B · vs all stocks (USD)
Updated Oct 23, 2026
EBITDA (TTM)
4.81BCNY
721.01M · vs all stocks (USD)
Updated Oct 23, 2026
Net Income (TTM)
3.72BCNY
557.64M · vs all stocks (USD)
Updated Oct 23, 2026
Quarterly Earnings Growth (YoY)
56.20%
Updated Oct 23, 2026
Operating Cash Flow (TTM)
6.76BCNY
1.01B · vs all stocks (USD)
Updated Oct 23, 2026
Levered Free Cash Flow (TTM)
3.38BCNY
507.06M · vs all stocks (USD)
Updated Oct 23, 2026
Trailing Annual Dividend Rate
0.2600CNYUpdated Oct 23, 2026
Trailing Annual Dividend Yield
0.98%
vs all stocks
Updated Oct 23, 2026
5-Year Average Dividend Yield
0.80%
vs all stocks
Updated Oct 23, 2026
Payout Ratio
27.52%
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 23.85%.Updated Oct 23, 2026
Minority Interest (Equity)
920.38MCNYFY2025 · Dec 31, 2025
Revenue
52.50BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
45.22BCNYFY2025 · Dec 31, 2025
Gross Profit
7.28BCNYFY2025 · Dec 31, 2025
Operating Income
3.20BCNY
479.12M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
3.40BCNYFY2025 · Dec 31, 2025
Income Tax Expense
467.69MCNYFY2025 · Dec 31, 2025
Net Income
2.94BCNYFY2025 · Dec 31, 2025
EBIT
3.50BCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
5.17BCNYFY2025 · Dec 31, 2025
Research & Development
2.08BCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
907.88MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
187.50MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
212.98MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
96.53MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.8570CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.8510CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
3.39BSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
3.39BSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
2.94BCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-32.97MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
1.88BCNYFY2025 · Dec 31, 2025
Free Cash Flow
320.07MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
16.89BCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
2.94BCNYFY2025 · Dec 31, 2025
Other Non-cash Items
72.15MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
1.12BCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-2.24BCNYFY2025 · Dec 31, 2025
Capital Expenditures
-1.56BCNYFY2025 · Dec 31, 2025
Net Acquisitions
-140.83MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-875.40MCNYFY2025 · Dec 31, 2025
Sale of Investments
366.23MCNYFY2025 · Dec 31, 2025
Other Investing Activity
-8.50MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-2.22BCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
3.54BCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-4.14BCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-1.11BCNYFY2025 · Dec 31, 2025
Other Financing Charges
81.12MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-1.64BCNYFY2025 · Dec 31, 2025
Shares Outstanding
3.41BSharesUpdated Oct 23, 2026
Float Shares
2.61BSharesUpdated Oct 23, 2026
% Held by Insiders
23.14%
vs all stocks
Updated Oct 23, 2026
% Held by Institutions
11.69%
vs all stocks
Updated Oct 23, 2026
Total Cash (MRQ)
17.07BCNY
2.56B · vs all stocks (USD)
Updated Oct 23, 2026
Total Cash per Share (MRQ)
5.01CNYUpdated Oct 23, 2026
Total Debt (MRQ)
3.28BCNY
491.27M · vs all stocks (USD)
Updated Oct 23, 2026
Total Debt to Equity (MRQ)
0.0832x
Updated Oct 23, 2026
Current Ratio (MRQ)
1.95x
Updated Oct 23, 2026
Book Value per Share (MRQ)
11.29CNYUpdated Oct 23, 2026
Total Assets
62.11BCNY
9.31B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
44.22BCNYFY2025 · Dec 31, 2025
Total Liabilities
23.67BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
17.89BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
2.80BCNYFY2025 · Dec 31, 2025
Total Current Liabilities
20.86BCNYFY2025 · Dec 31, 2025
Cash
16.50BCNYFY2025 · Dec 31, 2025
Cash Equivalents
1.47BCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
17.97BCNYFY2025 · Dec 31, 2025
Accounts Receivable
14.36BCNYFY2025 · Dec 31, 2025
Inventory
7.84BCNYFY2025 · Dec 31, 2025
Accounts Payable
13.14BCNYFY2025 · Dec 31, 2025
Short-term Debt
1.76BCNYFY2025 · Dec 31, 2025
Other Current Liabilities
271.83MCNYFY2025 · Dec 31, 2025
Long-term Debt
1.60BCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
88.90MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
3.41BCNYFY2025 · Dec 31, 2025
Retained Earnings
20.25BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
38.44BCNY
5.76B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
216.29MCNYFY2025 · Dec 31, 2025
52-Week Low
15.38CNYUpdated Oct 23, 2026
52-Week High
68.10CNYUpdated Oct 23, 2026
52-Week Change
48.80%
vs all stocks
Updated Oct 23, 2026
Beta
0.2310x
vs all stocks
Updated Oct 23, 2026
50-Day MA
32.63CNYUpdated Oct 23, 2026
200-Day MA
33.96CNYUpdated Oct 23, 2026
Avg 10-Day Volume
116.86MSharesUpdated Oct 23, 2026
Avg 30-Day Volume
166.67MSharesUpdated Oct 23, 2026
Diluted EPS (TTM)
1.09CNYUpdated Oct 23, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
A run of down weeks on a company profitable three years running and funded by equity.
Reads
Where is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 4.33: safe zoneNotable
Altman Z-Score: 4.33
Supply Chain
Downstream position: depends on 11 industries, supplies 6Notable
Outgoing: 6.00Incoming: 11.00
High connectivity hub: 17 industry connectionsNotable
Total Connections: 17.00
Scale
Market cap is $14.12B, above the global median of $1.15BNotable
Market cap (USD): 14,117,769,310.665Global Median: 1,150,342,212.262
Revenue is $8.97B, above the global median of $559.35MNotable